联系客服

600535 沪市 天士力


首页 公告 天士力:天士力关于公司2024年半年度主要经营数据的公告

天士力:天士力关于公司2024年半年度主要经营数据的公告

公告日期:2024-08-24

天士力:天士力关于公司2024年半年度主要经营数据的公告 PDF查看PDF原文

          证券代码:600535        证券简称:天士力        编号:临 2024-038 号

                        天士力医药集团股份有限公司

                  关于公司 2024 年半年度主要经营数据的公告

              本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述

          或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。

              根据上海证券交易所发布的上市公司分行业信息披露指引《上市公司行业信

          息披露指引第六号——医药制造》及《关于做好上市公司 2024 年半年度报告披

          露工作的通知》相关要求,现将公司 2024 年半年度主要经营数据披露如下:

              一、报告期内分行业经营数据

                                                                        单位:元    币种:人民币

                    主营业务收入                            主营业务成本                  毛利率(%)

行业                                    增长                                    增长    2024  2023  增长
      2024 年 1-6 月    2023 年 1-6 月    率    2024 年 1-6 月    2023 年 1-6 月  率(%) 年 1-6  年 1-6  率
                                        (%)                                            月      月

医药  3,896,198,306.32  3,726,811,778.92  4.55  1,098,534,686.76  1,012,959,237.91  8.45    71.80  72.82  -1.01
工业

医药  453,702,295.72    630,869,258.96  -28.08  310,039,942.77  456,344,156.48  -32.06  31.66  27.66  4.00
商业

合计  4,349,900,602.04  4,357,681,037.88  -0.18  1,408,574,629.53  1,469,303,394.39  -4.13  67.62  66.28  1.34

                                                                        单位:元    币种:人民币

    分治疗领域      营业收入        营业成本      毛利率  营业收入比上  营业成本比上  毛利率比上

                                                      (%)  年增减(%)  年增减(%)  年增减(%)

      心脑血管    2,791,924,109.56  751,163,505.87    73.10        6.60          15.64          -2.10

      抗肿瘤      104,687,846.04    29,050,432.57    72.25        20.20          -13.91        11.00

      感冒发烧    183,587,682.71    64,615,536.35    64.80      -37.39        -40.15          1.62

      肝病治疗    345,229,579.12    68,560,550.91    80.14        17.15          24.16          -1.12

        其他      470,769,088.89    185,144,661.06    60.67        8.77          11.24          -0.87

    医药工业小计  3,896,198,306.32  1,098,534,686.76    71.80        4.55          8.45          -1.01

    医药商业小计  453,702,295.72    310,039,942.77    31.66      -28.08        -32.06          4.00

        合计      4,349,900,602.04  1,408,574,629.53    67.62        -0.18          -4.13          1.34

                                                                        单位:元    币种:人民币

      分产品        营业收入        营业成本      毛利率    营业收入比上  营业成本比上  毛利率比上

                                                    (%)    年增减(%)  年增减(%)  年增减(%)

        中药      3,121,487,301.77  906,608,342.90    70.96        3.53          8.75          -1.39

    化学制剂药    630,987,946.82    123,284,773.51    80.46        12.57          4.34          1.54


 化学原料药    37,210,159.70    22,025,836.52    40.81        3.90          25.10        -10.03

  生物药      106,512,898.03    46,615,733.83    56.23        -7.75          7.13          -6.08

医药工业小计  3,896,198,306.32  1,098,534,686.76    71.80        4.55          8.45          -1.01

医药商业小计  453,702,295.72    310,039,942.77    31.66        -28.08          -32.06        4.00

    合计      4,349,900,602.04  1,408,574,629.53    67.62        -0.18          -4.13          1.34

          报告期内,公司感冒发烧产品收入较上年同期下降 37.39%,主要系报告期内

      藿香正气滴丸和穿心莲内酯滴丸销量下降所致。

          二、报告期内分地区经营数据

                                                    单位:元  币种:人民币

      地区              本期累计主营业务收入        上年同期累计主营业务收入    增长比例(%)

    天津市                      7,288,249,352.36                7,274,286,807.11                0.19

    上海市                      106,512,898.03                  115,446,980.91                -7.74

    山东省                      124,684,091.02                  138,497,172.55                -9.97

    陕西省                        46,203,564.05                  39,306,969.37                17.55

    辽宁省                      437,118,522.21                  490,027,805.11                -10.80

    江苏省                      389,058,975.28                  352,040,841.52                10.52

      其他                        106,562,313.07                  93,730,982.97                13.69

      小计                      8,498,389,716.02                8,503,337,559.54                -0.06

      抵消                      4,148,489,113.98                4,145,656,521.66                0.07

      合并                      4,349,900,602.04                4,357,681,037.88                -0.18

            注:该表地区分布以公司及子公司所在地划分。

          本公告之经营数据未经审计,提醒投资者审慎使用上述数据。

          特此公告。

                                            天士力医药集团股份有限公司董事会

                                                    2024 年 8 月 24 日

[点击查看PDF原文]